# Under Armour, Inc.: financial statements, quarterly

UAA · NYSE · CIK 1336917 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/uaa.md) · [Financials](/companies/uaa/financials.md) · [Filings](/companies/uaa/filings.md) · [Insiders](/companies/uaa/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/uaa/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,567](/filings/0001336917-24-000168.md) | [1,486](/filings/0001336917-25-000016.md) | [1,332](/filings/0001336917-24-000073.md) | [1,184](/filings/0001336917-25-000136.md) | [1,399](/filings/0001336917-25-000198.md) | [1,401](/filings/0001336917-26-000027.md) | [1,181 d](/filings/0001336917-26-000073.md) | [1,134](/filings/0001336917-26-000111.md) | [1,333](/filings/0001336917-25-000198.md) | [1,328](/filings/0001336917-26-000027.md) | [1,171 d](/filings/0001336917-26-000073.md) | [1,098](/filings/0001336917-26-000111.md) |
| Cost of revenue | $m | [818](/filings/0001336917-24-000168.md) | [815](/filings/0001336917-25-000016.md) | [733](/filings/0001336917-24-000073.md) | [621](/filings/0001336917-25-000136.md) | [703](/filings/0001336917-25-000198.md) | [736](/filings/0001336917-26-000027.md) | [630 d](/filings/0001336917-26-000073.md) | [588](/filings/0001336917-26-000111.md) | [703](/filings/0001336917-25-000198.md) | [738](/filings/0001336917-26-000027.md) | [679 d](/filings/0001336917-26-000073.md) | [504](/filings/0001336917-26-000111.md) |
| Gross profit | $m | [749](/filings/0001336917-24-000168.md) | [671](/filings/0001336917-25-000016.md) | [600](/filings/0001336917-24-000073.md) | [563](/filings/0001336917-25-000136.md) | [696](/filings/0001336917-25-000198.md) | [665](/filings/0001336917-26-000027.md) | [551 d](/filings/0001336917-26-000073.md) | [546](/filings/0001336917-26-000111.md) | [631](/filings/0001336917-25-000198.md) | [590](/filings/0001336917-26-000027.md) | [492 d](/filings/0001336917-26-000073.md) | [594](/filings/0001336917-26-000111.md) |
| Selling, general and administrative | $m | [609](/filings/0001336917-24-000168.md) | [599](/filings/0001336917-25-000016.md) | [603](/filings/0001336917-24-000073.md) | [837](/filings/0001336917-25-000136.md) | [520](/filings/0001336917-25-000198.md) | [638](/filings/0001336917-26-000027.md) | [607 d](/filings/0001336917-26-000073.md) | [530](/filings/0001336917-26-000111.md) | [582](/filings/0001336917-25-000198.md) | [665](/filings/0001336917-26-000027.md) | [518 d](/filings/0001336917-26-000073.md) | [543](/filings/0001336917-26-000111.md) |
| Operating income | $m | [139](/filings/0001336917-24-000168.md) | [71.4](/filings/0001336917-25-000016.md) | [(3.6)](/filings/0001336917-24-000073.md) | [(300)](/filings/0001336917-25-000136.md) | [173](/filings/0001336917-25-000198.md) | [13.5](/filings/0001336917-26-000027.md) | [(72.1) d](/filings/0001336917-26-000073.md) | [3.3](/filings/0001336917-26-000111.md) | [17.0](/filings/0001336917-25-000198.md) | [(150)](/filings/0001336917-26-000027.md) | [(33.7) d](/filings/0001336917-26-000073.md) | [46.7](/filings/0001336917-26-000111.md) |
| Income tax | $m | [28.4](/filings/0001336917-24-000168.md) | [8.6](/filings/0001336917-25-000016.md) | [(11.3)](/filings/0001336917-24-000073.md) | [5.1](/filings/0001336917-25-000136.md) | [(2.1)](/filings/0001336917-25-000198.md) | [6.3](/filings/0001336917-26-000027.md) | [(12.2) d](/filings/0001336917-26-000073.md) | [(2.7)](/filings/0001336917-26-000111.md) | [25.9](/filings/0001336917-25-000198.md) | [271](/filings/0001336917-26-000027.md) | [0.9 d](/filings/0001336917-26-000073.md) | [28.3](/filings/0001336917-26-000111.md) |
| Net income | $m | [105](/filings/0001336917-24-000168.md) | [111](/filings/0001336917-25-000016.md) | [6.6](/filings/0001336917-24-000073.md) | [(305)](/filings/0001336917-25-000136.md) | [170](/filings/0001336917-25-000198.md) | [1.2](/filings/0001336917-26-000027.md) | [(67.5) d](/filings/0001336917-26-000073.md) | [(2.6)](/filings/0001336917-26-000111.md) | [(18.8)](/filings/0001336917-25-000198.md) | [(431)](/filings/0001336917-26-000027.md) | [(43.4) d](/filings/0001336917-26-000073.md) | [0.5](/filings/0001336917-26-000111.md) |
| Diluted EPS | $ per share | [0.23](/filings/0001336917-24-000168.md) | [0.25](/filings/0001336917-25-000016.md) | [0.02](/filings/0001336917-24-000073.md) | [(0.70)](/filings/0001336917-25-000136.md) | [0.39](/filings/0001336917-25-000198.md) | [0.00](/filings/0001336917-26-000027.md) | not reported | [(0.01)](/filings/0001336917-26-000111.md) | [(0.04)](/filings/0001336917-25-000198.md) | [(1.01)](/filings/0001336917-26-000027.md) | not reported | [0.00](/filings/0001336917-26-000111.md) |
| Basic EPS | $ per share | [0.24](/filings/0001336917-24-000168.md) | [0.25](/filings/0001336917-25-000016.md) | [0.02](/filings/0001336917-24-000073.md) | [(0.70)](/filings/0001336917-25-000136.md) | [0.39](/filings/0001336917-25-000198.md) | [0.00](/filings/0001336917-26-000027.md) | not reported | [(0.01)](/filings/0001336917-26-000111.md) | [(0.04)](/filings/0001336917-25-000198.md) | [(1.01)](/filings/0001336917-26-000027.md) | not reported | [0.00](/filings/0001336917-26-000111.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [655](/filings/0001336917-24-000168.md) | [1,039](/filings/0001336917-25-000016.md) | [859](/filings/0001336917-26-000073.md) | [885](/filings/0001336917-25-000136.md) | [531](/filings/0001336917-25-000198.md) | [727](/filings/0001336917-26-000027.md) | [501](/filings/0001336917-26-000073.md) | [911](/filings/0001336917-26-000111.md) | [396](/filings/0001336917-25-000198.md) | [465](/filings/0001336917-26-000027.md) | [309](/filings/0001336917-26-000111.md) | [396](/filings/0001336917-26-000111.md) |
| Current assets | $m | [2,872](/filings/0001336917-23-000048.md) | [3,123](/filings/0001336917-24-000024.md) | [2,864](/filings/0001336917-25-000078.md) | [2,968](/filings/0001336917-24-000117.md) | [2,570](/filings/0001336917-24-000168.md) | [2,691](/filings/0001336917-25-000016.md) | [2,329](/filings/0001336917-26-000073.md) | [2,903](/filings/0001336917-25-000136.md) | [2,944](/filings/0001336917-25-000198.md) | [2,989](/filings/0001336917-26-000027.md) | [2,719](/filings/0001336917-26-000111.md) | [2,369](/filings/0001336917-26-000111.md) |
| Total assets | $m | [4,747](/filings/0001336917-23-000048.md) | [5,045](/filings/0001336917-24-000024.md) | [4,761](/filings/0001336917-25-000078.md) | [4,861](/filings/0001336917-24-000117.md) | [4,495](/filings/0001336917-24-000168.md) | [4,631](/filings/0001336917-25-000016.md) | [4,301](/filings/0001336917-26-000073.md) | [4,865](/filings/0001336917-25-000136.md) | [4,899](/filings/0001336917-25-000198.md) | [4,630](/filings/0001336917-26-000027.md) | [4,416](/filings/0001336917-26-000111.md) | [4,098](/filings/0001336917-26-000111.md) |
| Current liabilities | $m | [1,283](/filings/0001336917-23-000048.md) | [1,466](/filings/0001336917-24-000024.md) | [1,165](/filings/0001336917-25-000078.md) | [1,718](/filings/0001336917-24-000117.md) | [1,181](/filings/0001336917-24-000168.md) | [1,341](/filings/0001336917-25-000016.md) | [1,109](/filings/0001336917-26-000073.md) | [1,895](/filings/0001336917-25-000136.md) | [1,737](/filings/0001336917-25-000198.md) | [2,089](/filings/0001336917-26-000027.md) | [1,677](/filings/0001336917-26-000111.md) | [1,309](/filings/0001336917-26-000111.md) |
| Total liabilities | $m | [2,657](/filings/0001336917-23-000048.md) | [2,871](/filings/0001336917-24-000024.md) | [2,607](/filings/0001336917-25-000078.md) | [3,044](/filings/0001336917-24-000117.md) | [2,509](/filings/0001336917-24-000168.md) | [2,646](/filings/0001336917-25-000016.md) | [2,411](/filings/0001336917-26-000073.md) | [2,991](/filings/0001336917-25-000136.md) | [3,044](/filings/0001336917-25-000198.md) | [3,195](/filings/0001336917-26-000027.md) | [3,001](/filings/0001336917-26-000111.md) | [2,670](/filings/0001336917-26-000111.md) |
| Long-term debt | $m | [595](/filings/0001336917-23-000048.md) | [595](/filings/0001336917-24-000024.md) | [595](/filings/0001336917-25-000078.md) | [595](/filings/0001336917-24-000117.md) | [595](/filings/0001336917-24-000168.md) | [595](/filings/0001336917-25-000016.md) | [595](/filings/0001336917-26-000073.md) | [389](/filings/0001336917-25-000136.md) | [590](/filings/0001336917-25-000198.md) | [390](/filings/0001336917-26-000027.md) | [591](/filings/0001336917-26-000111.md) | [591](/filings/0001336917-26-000111.md) |
| Current portion of debt | $m | [80.9](/filings/0001336917-23-000048.md) | [80.9](/filings/0001336917-24-000024.md) | [80.9](/filings/0001336917-25-000078.md) | [0.0](/filings/0001336917-24-000117.md) | [0.0](/filings/0001336917-24-000168.md) | [0.0](/filings/0001336917-25-000016.md) | [0.0](/filings/0001336917-26-000073.md) | [600](/filings/0001336917-25-000136.md) | [599](/filings/0001336917-25-000198.md) | [600](/filings/0001336917-26-000027.md) | [600](/filings/0001336917-26-000111.md) | [0.0](/filings/0001336917-26-000111.md) |
| Shareholders' equity | $m | [2,054](/filings/0001336917-25-000016.md) | [2,134](/filings/0001336917-25-000016.md) | [2,153](/filings/0001336917-26-000073.md) | [1,817](/filings/0001336917-25-000198.md) | [1,985](/filings/0001336917-26-000027.md) | [1,985](/filings/0001336917-26-000027.md) | [1,890](/filings/0001336917-26-000111.md) | [1,874](/filings/0001336917-26-000111.md) | [1,856](/filings/0001336917-26-000027.md) | [1,435](/filings/0001336917-26-000027.md) | [1,414](/filings/0001336917-26-000111.md) | [1,428](/filings/0001336917-26-000111.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [61.5 d](/filings/0001336917-24-000168.md) | [421 d](/filings/0001336917-25-000016.md) | [(123) d](/filings/0001336917-26-000073.md) | [153](/filings/0001336917-25-000136.md) | [(321) d](/filings/0001336917-25-000198.md) | [311 d](/filings/0001336917-26-000027.md) | [(202) d](/filings/0001336917-26-000073.md) | [48.9](/filings/0001336917-26-000111.md) | [(69.8) d](/filings/0001336917-25-000198.md) | [278 d](/filings/0001336917-26-000027.md) | [(332) d](/filings/0001336917-26-000073.md) | [109](/filings/0001336917-26-000111.md) |
| Capital expenditure | $m | [42.8 d](/filings/0001336917-24-000168.md) | [41.2 d](/filings/0001336917-25-000016.md) | [33.8 d](/filings/0001336917-26-000073.md) | [45.7](/filings/0001336917-25-000136.md) | [45.8 d](/filings/0001336917-25-000198.md) | [48.4 d](/filings/0001336917-26-000027.md) | [28.8 d](/filings/0001336917-26-000073.md) | [35.4](/filings/0001336917-26-000111.md) | [20.5 d](/filings/0001336917-25-000198.md) | [16.1 d](/filings/0001336917-26-000027.md) | [15.1 d](/filings/0001336917-26-000073.md) | [14.6](/filings/0001336917-26-000111.md) |
| Share repurchases | $m | [50.0 d](/filings/0001336917-24-000168.md) | [25.0 d](/filings/0001336917-25-000016.md) | [0.0 d](/filings/0001336917-26-000073.md) | [40.0](/filings/0001336917-25-000136.md) | [0.0 d](/filings/0001336917-25-000198.md) | [25.0 d](/filings/0001336917-26-000027.md) | [25.0 d](/filings/0001336917-26-000073.md) | [0.0](/filings/0001336917-25-000136.md) | [25.0 d](/filings/0001336917-25-000198.md) | [0.0 d](/filings/0001336917-26-000027.md) | [0.0 d](/filings/0001336917-26-000073.md) | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2023 (2022-09-30) | Q3 FY2023 (2022-12-31) | Q1 FY2024 (2023-06-30) | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [464](/filings/0001336917-23-000048.md) | [459](/filings/0001336917-24-000024.md) | [455](/filings/0001336917-24-000117.md) | [454](/filings/0001336917-24-000168.md) | [448](/filings/0001336917-25-000016.md) | [436](/filings/0001336917-25-000136.md) | [436](/filings/0001336917-25-000198.md) | [437](/filings/0001336917-26-000027.md) | [427](/filings/0001336917-26-000111.md) | [428](/filings/0001336917-25-000198.md) | [425](/filings/0001336917-26-000027.md) | [432](/filings/0001336917-26-000111.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.